Login to Your Account

ML Labs Acquiring Quadrant For £46.7M As Part Of Restructuring

By Nuala Moran

Wednesday, June 22, 2005
LONDON - ML Laboratories plc is buying pulmonary drug formulation specialist Quadrant Technologies Ltd. for £46.7 million (US$85 million) in cash and shares, and changing its name to Innovata plc to reflect the transformation the acquisition will bring. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription